ArticleJournal of gastric cancer2026
Real-World Evidence for Expanding the Criteria for Endoscopic Resection in Submucosal Gastric Cancer: The Role of Invasion Width.
Article in Journal of gastric cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe current expanded criteria for endoscopic resection (ER) of early gastric cancer (EGC) include a non-negligible risk of lymph node metastasis (LNM) in submucosal (SM) disease. We had previously proposed revised criteria incorporating the SM invasion width to better stratify LNM risk. In the present study, we aimed to validate whether these revised criteria improved the identification of truly node-negative, differentiated-type pT1b EGC. MATERIAL AND
methodsThis multicenter retrospective study included 712 patients with differentiated-type SM invasive EGC who underwent gastrectomy at 2 tertiary centers between 2016 and 2023. The SM invasion depth and width were re-evaluated, and the diagnostic performance of the conventional, expanded, and revised criteria (tumor size ≤3 cm, SM depth ≤1,000 µm, SM width ≤4 mm, and no lymphovascular/perineural invasion) for predicting LNM was compared.
resultsLNM was identified in 16.9% of the patients. An SM invasion width >4 mm was a strong independent predictor of LNM (P<0.001) and demonstrated superior discriminatory ability (area under the receiver operating characteristic curve [AUC], 0.79) in comparison with SM depth (AUC, 0.68) and tumor size (AUC, 0.59). Although the conventional criteria classified 54 cases as curative, the revised criteria classified 83 cases as curative, and no LNM events were observed in both sets of cases. Thus, the revised criteria expanded the potential candidate pool for curative ER by approximately 54% without compromising nodal safety.
conclusionsSM invasion width can be a significant independent predictor of LNM. The revised criteria, which incorporated SM width, safely expanded the indications for curative ER in patients with differentiated-type SM gastric cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.